Article

Feds: Jury awards are to blame for insurance hikes

Author(s):

Bob Gatty

Washington-Congress has been told by its chief investigative agency thatincreasing medical liability awards, indeed, are contributing to skyrocketingpremium costs for many physicians, but that fact is not having a widespreadimpact on patients' access to health care.

Related Videos
Amy Pearlman, MD, answers a question during a video interview
Team of surgeons | Image Credit: © shefkate - stock.adobe.com
Prostate cancer cells dividing | Image Credit: © PRB ARTS - stock.adobe.com
Blur image of hospital corridor | Image Credit: © zephyr_p - stock.adobe.com
Marah C. Hehemann, MD, answers a question during a video interview
Crop shot of senior man sitting on sofa with doctor during home visit taking notes on clipboard | Image Credit: © DragonImages - stock.adobe.com
Related Content
FDA approves oral sulopenem for uncomplicated urinary tract infection
Published: October 25th 2024 | Updated: October 25th 2024

FDA approves oral sulopenem for uncomplicated urinary tract infection

Hannah Clarke
The approval is supported by data from the phase 3 SURE 1 and REASSURE trials.
Key updates from the AUA/ASRM male infertility guideline amendment
September 23rd 2024

Key updates from the AUA/ASRM male infertility guideline amendment

Urology Times staff
In this episode, Robert E. Brannigan, MD, and Juan J. Andino, MD, MBA, discuss the recent amendment to the AUA/ASRM guideline on male infertility.
Comparable efficacy seen with single vs. multiple OnabotulinumtoxinA injection sites in OAB
October 24th 2024

Comparable efficacy seen with single vs. multiple OnabotulinumtoxinA injection sites in OAB

Hannah Clarke
At 1 month, the mean decrease in the OAB-Q symptom severity subscale score was -31.2 in the 1-injection cohort vs -39.5 in the 10-injection cohort.
Speaking of Urology: Dr. Winter on the use of vaginal estrogen
July 24th 2024

Speaking of Urology: Dr. Winter on the use of vaginal estrogen

Urology Times staff
In this episode of Speaking of Urology®, Ashley G. Winter, MD, discusses the use of vaginal estrogen.
FDA grants 510(k) clearance to Ambu’s HD cystoscopy solution
October 23rd 2024

FDA grants 510(k) clearance to Ambu’s HD cystoscopy solution

Hannah Clarke
The cystoscopy solution was granted a CE mark for regulatory clearance in Europe in October 2023.
Trial launches of 61Cu-based radiotracer in PSMA-positive prostate cancer
October 23rd 2024

Trial launches of 61Cu-based radiotracer in PSMA-positive prostate cancer

Hannah Clarke
The trial is comparing the diagnostic performance of 61Cu-NODAGA-PSMA I&T with that of 18F-piflufolastat.
© 2024 MJH Life Sciences

All rights reserved.